| abstract |
(57) [Summary] A therapeutic agent for inflammatory bowel disease comprising fat and protein as active ingredients. The fatty acid composition of fat is 0 to 6 medium-chain fatty acids. 0%, ω3 fatty acid 3 to 20% and ω6 fatty acid 10 40%, ω3 fatty acid / ω6 fatty acid is 1/6 That is all. The protein may be a degradation product or an amino acid, and when it is a protein, milk protein / soy protein is used at 1/3 to 3/1. [Effect] To treat inflammatory bowel disease such as Crohn's disease and ulcerative bowel disease by oral or tube administration, improve nutritional status of patients with inflammatory bowel disease, suppress the occurrence of diarrhea, and improve anemia. You can |